Table 2. Gender, genotype and phenotype.
Sex | WT (n=870) | HREM (n=189) |
Male | 564 (64.8%) | 101 (53.4%) |
Female | 306 (35.2%) | 88 (46.6%) |
Site of symptom onset | WT (n=818) | HREM (n=203) |
Bulbar | 219 (26.8%) | 77 (37.9%) |
Spinal | 573 (70%) | 110 (54.1%) |
FTD | 26 (3.2%) | 16 (8%) |
Male to female ratios and frequencies of limb, bulbar and FTD onset in WT and HREM-positive cases.